Neucure Lifesciences Private Limited
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.mg)
Glimzab MV3 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimzab MV3 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimzab MV3 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimzab MV3 Tablet SR.
Glimzab MV3 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimzab MV3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimzab MV3 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimzab MV3 Tablet SR is a prescription medication that contains a combination of three active ingredients: Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, helping to improve blood glucose levels when taken with a healthy diet and regular exercise.
Common side effects of Glimzab MV3 Tablet SR may include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimzab MV3 Tablet SR should not be used by patients with a known allergy to any of its components or excipients. It is also contraindicated in patients with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
No, consuming alcohol while taking Glimzab MV3 Tablet SR may lower blood sugar levels and increase the risk of lactic acidosis. It is recommended to avoid alcohol when using this medication.
Yes, Glimzab MV3 Tablet SR can cause low blood sugar levels (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood glucose levels is essential, especially when taking this medication with other antidiabetic medicines, delaying meals, or engaging in strenuous exercise.
Store Glimzab MV3 Tablet SR in its original packet or container, tightly closed. Dispose of unused medication properly to prevent accidental ingestion by pets, children, or other individuals.